Nöroloji ve Covid-19

TC Sağlık Bakanlığı. Covid-19-Sars-Cov-2 Enfeksiyonu Rehberi (Bilim Kurulu Çalışması) 14.4.2020.

Acar T, Demirel EA, Afşar N, Akçalı A, Demir GA, Alagöz AN, et al. Nörolojik Bakış Açısından COVID-19. Turk J Neurol. 2020;26: 56-106.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China. N Engl J Med. 2020;382:727-733

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:1-9.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506.

Romoli M, Jelcic I, Bernard-Valnet R, García Azorín D, Mancinelli L, Akhvlediani T, et al. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details. Eur J Neurol 2020;10.1111/ene.14382.

Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review. J Neurol Sci 2020;413:116832.

Romero-Sanchez CM, Diaz-Maroto I, Fernandez-Diaz E, Sanchez-Larsen A, Layos-Romero A, Garcia-Garcia J, et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBA COVID registry. Neurology 2020;95(8):1060-1070.

Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020;94:e00127-e220

To KF, Tong JH, Chan PK, Au FW, Chim SS, Chan KA, et al. Tissue and cellular tropism of the coronavirüs associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases. J Pathol. 2004;202:157-63.

Muus C, Luecken MD, Eraslan G, Waghray A, Heimberg G, Sikkema L, et al. Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells. BioRxiv. 2020. doi.org/10.1101/2020.04.19.049254

Chen R, Wang K, Yu J, Chen Z, Wen C, Xu Z. The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and mouse brain. Neuroscience. 2020. doi. org/10.1101/2020.04.07.030650

Qi J, Zhou Y, Hua J, Zhang L, Bian J, Liu B, et al. The scRNA-seq expression profling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to COVID-19 infection. Bioinformatics. 2020. doi.org/10.1101/2020.04.16.045690

Gu J, Gong E, Zhang B, Zheng J, Gao Z, Zhong Y, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202:415-424

Kabbani N, Olds JL. Does COVID19 infect the brain? If so, smokers might be at a higher risk. Mol Pharmacol. 2020;97:351-353

Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020: doi.org/10.1001/jamaneurol .2020.2065

Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11:995-998

Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92:552-555

Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82:7264-7275

Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dube M, et al. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2019;12(1):14

Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Vuhan, China: a retrospective case series study. 2020 medRxiv .

Lau KK, Yu WC, Chu CM, Lau ST, Sheng B, Yuen KY. Possible central nervous system infection by SARS coronavirüs. Emerg Infect Dis 2004;10:342-344.

Jin H HC, Chen S, Zhou Y, Wang Y, Mao L, et al. Consensus for prevention and management of coronavirüs disease 2019 (COVID-19) for neurologists Stroke & Vascular Neurology 2020. doi:10.1136/svn-2020-000382.

Ozturk S. COVID-19 ve Nöroloji. Turk J Neurol 2020.

Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J et al. A first case of meningitis/encephalitis associated with SARS-Coronavirüs-2. Int J Infect Dis 2020;94:55-58.

Baig AM. Neurological manifestations in COVID-19 caused by SARSCoV-2. CNS Neurosci Ther. 2020;26:499-501.

Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features. Radiology. 2020:201187

Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L, et al. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis 2020;71:189-190.

Fitzgerald S. Loss of Smell as an Early Symptom of COVID-19: What Research Is Uncovering: American Academy of Neurology. (2020). Available online at: https://journals.lww.com/neurotodayonline/blog/breakingnews/ pages/post.aspx?PostID=928 (accessed April 12, 2020)

Steardo L, Steardo LJr., Zorec R, Verkhratsky A. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol (Oxf). 2020;229(30):e13473. doi: 10.1111/apha.13473.

Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18-22.

Bostanciklioğlu M. SARS-CoV2 entry and spread in the lymphatic drainage system of the brain. Brain Behav Immun. 2020;87:122-123.

Li Z, Liu T, Yang N, Han D, Mi X, Li Y, et al. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain. Front Med. 2020. doi: 10.1007/s11684-020- 0786-5

Needham EJ, Chou SH, Coles AJ, Menon DK. Neurological implications of COVID-19 infections. Neurocrit Care. 2020. 32(3):667-671.

Bolay H, Gül A, Baykan B. COVID-19 is a Real Headache, Headache. 2020. doi.org/10.1111/head.13856

Vacchiano V, Riguzzi P, Volpi L, Tappata M, Avoni P, Rizzo G, et al. Early neurological manifestations of hospitalized COVID-19 patients. Neurological Sciences. 2020;41(8):2029-2031.

MaassenVanDenBrink A, De Vries T, Danser AJ. Headache medication and the COVID-19 pandemic. The Journal of Headache and Pain. 2020;21(1), 1-4.

Ellul MA, Benjamin L, Singh B, Lant S, Michael, B, Kneen R, et al. Neurological associations of COVID-19. Lancet Neurol. 2020. doi:10.1016/S1474-4422(20)30221-0

Laurendon T, Radulesco T, Mugnier J, Gerault M, Chagnaud C, ElAhmadi AA, et al. Bilateral transient olfactory bulb edema during COVID-19 related anosmia. Neurology 2020;95:224-225.

Politi LS, Salsano E and Grimaldi M. Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol 2020;77:1028-1029

Held P, Seitz J, Fründ R, Nitz WR, Haffke T, Hees H and Bonkowsky V: MRI detection of olfactory bulb and tract. J Neuroradiol 2000;27:112-118.

Kirchdoerfer RN, Wang N, Pallesen J, Wrapp D, Turner HL, Cottrell CA, et al. Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis. Scientific reports. 2018;8(1):1-11.

Finsterer J, Stollberger C. Causes of hypogeusia/hyposmia in SARS-CoV2 infected patients. J Med Virol 2020. doi:10.1002/jmv.25903.

Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence?. The Lancet Neurology. 2020;19(5);383-384.

Jacobs BC, Rothbarth P H, VanderMeche FGA, Herbrink P, Schmitz PIM, De Klerk MA, et al. The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study. Neurology. 1998;51(4):1110-1115.

Haber P. Guillain-Barre syndrome following influenza vaccination. JAMA. 2004;292:2478.

Cao-Lormeau VM, Blake AMS, Lastere SRC, Vanhomwegen J, Ghawche F. Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. The Lancet. 2016;387(10027):1531-1539.

Fantini J, Chahinian H, Yahi N. Synergistic antiviral effect of hydro-xychloroquine and azithromycin in combination against SARS-CoV-2:what molecular dynamics studies of virus-host interactions reveal. IntJ Antimicrob Agents. 2020;106020:1-9

Vaduganathan M, Vardeny O, Michel T, McMurray JJV, PfefferMA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19. N Engl J Med. 2020;382:1653-1659.

Dalakas MC. Guillain-Barre syndrome: the first documented COVID-19-triggered autoimmune neurologic disease: more to come with myositis in the offing. Neurol Neuroimmunol Neuroinflamm. 2020;7:5.

Hartung HP, Toyka KV. T-cell and macrophage activation in experi-mental autoimmune neuritis and Guillain-Barre syndrome. Ann Neurol. 1990;27(1):57-63.

Pilotto A, Odolini S, Masciocchi S, Comelli A, Volonghi I, Gazzina S, et al. Steroid-responsive encephalitis in COVID-19 disease. Ann Neurol. 2020; doi: 10.1002/ana.25783.

Bernard-Valnet, Pizzarotti B, Anichini A, Demars Y, Russo E, Schmidhauser M, et al. Two patients with acute meningo-encephalitis concomitant to SARS-CoV-2 infection. Eur J Neurol. 2020; doi: 10.1111/ene.14298.

Liu K, Pan M, Xiao Z, Xu X. Neurological manifestations of the coronavirus (SARS-CoV-2) pandemic 2019-2020. J Neurol Neurosurg Psychiatry. 2020; 91(6):669-670. doi: 10.1136/jnnp2020-323177.

Leonardi M, Padovani A, McArthur JM. Neurological manifestations associated with COVID19: a review and a call for action. J Neurol. 2020; 1573-1576.

Wong AM, Simon EM, Zimmerman RA, Wang HS, Toh CH, Ng SH. Acute Necrotizing Encephalopathy of Childhood: Correlation of MR Findings and Clinical Outcome AJNR Am J Neuroradiol. 2006;27(9):1919-23.

Zhang T, Rodricks MB, Hirsh E. COVID-19-Associated Acute Disseminated Encephalomyelitis – A Case Report. 2020; medRxiv preprint doi: doi.org/10.1101/2020.04.16.20068148.

Toscano G, PalmeriniF, Ravalia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barre Syndrome Associated with SARS-CoV-2. N. Engl. J. Med. 2020; doi.org/10.1056/NEJMc2009191.

Hirano T, Murakami M. COVID-19: A new virus, but a familiar receptor and cytokine release syndrome. Immunity. 2020; doi.org/10.1016/ j.imunni.2020.04.003.

Hartung HP, Aktas O. COVID-19 and management of neuroimmunological disorders. Nature Reviews Neurology, 2020;1-2.

Leung TW, Wong KS, Hui AC, To KF, Lai ST, Ng WF, et al. Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series. Arch Neurol 2005;62:1113-1117

Markus HS, Brainin M. COVID-19 and stroke-A global World Stroke Organization perspective. International journal of stroke, 2020;15(4):361-364.

Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost. 2019;17(11):1989–94. doi.org/10.1111/jth.14578.

Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, et al. Tissue plasminogen activator (tPA) treatment for COVID19 associated acute respiratory distress syndrome (ARDS): a case series. J Thromb Haemost. 2020. doi.org/10.1111/jth. 14828.

Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, et al. Large-vessel stroke as a presenting feature of COVID-19 in the young. N Engl J Med. 2020;382(20):60.

Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020.

Carod-Artal FJ. Neurological complications of coronavirus and COVID-19. Rev Neurol. 2020;70(9):311-22.

Franceschi AM, Ahmed O, Giliberto L, Castillo M. Hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of COVID-19 infection. AJNR Am J Neuroradiol. 2020.

Yaghi S, Ishida K, Torres J, Grory BM, Raz E, Humbert K, et al. SARS2-CoV-2 and stroke in a New York healthcare system. Stroke. 2020;51(7):2002-11.

Qureshi AI, Abd-Allah F, Alsenani F, Aytac E. Borhani-Haghighi A, Ciccone A, et al. Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel. International Journal of Stroke, 2020; doi.org/10.1177/1747493020923234.